Furtado RHM, Raz I, Goodrich EL, Murphy SA, et al. Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial. Circulation 2022 May 5. doi: 10.1161/CIRCULATIONAHA.121.058103.
PMID: 35510542